APA (7th ed.) Citation

TC, S., MA, C., DB, S., A, G., P, M., ET, L., . . . BP, D. (2012). Phase 0 study of the inhibition of cholesteryl ester transfer protein activity by JNJ-28545595 in plasma from normolipidemic and dyslipidemic humans. International journal of clinical pharmacology and therapeutics, 50(8), 584. https://doi.org/10.5414/CP201627

Chicago Style (17th ed.) Citation

TC, Sarich, Connelly MA, Schranz DB, Ghosh A, Manitpisitkul P, Leary ET, Rothenberg P, Demarest KT, and Damiano BP. "Phase 0 Study of the Inhibition of Cholesteryl Ester Transfer Protein Activity by JNJ-28545595 in Plasma from Normolipidemic and Dyslipidemic Humans." International Journal of Clinical Pharmacology and Therapeutics 50, no. 8 (2012): 584. https://doi.org/10.5414/CP201627.

MLA (9th ed.) Citation

TC, Sarich, et al. "Phase 0 Study of the Inhibition of Cholesteryl Ester Transfer Protein Activity by JNJ-28545595 in Plasma from Normolipidemic and Dyslipidemic Humans." International Journal of Clinical Pharmacology and Therapeutics, vol. 50, no. 8, 2012, p. 584, https://doi.org/10.5414/CP201627.